|
Volumn 107, Issue 4, 1992, Pages 970-975
|
Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats
|
Author keywords
angiotensin converting enzyme inhibition; Aortic banding; cardiac hypertrophy; long term treatment; low dose ramipril; myocardial fibrosis
|
Indexed keywords
ANGIOTENSIN;
ANGIOTENSIN I;
BRADYKININ;
CYCLIC GMP;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
NORADRENALIN;
RAMIPRIL;
RENIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
AORTA CONSTRICTION;
ARTICLE;
BLOOD PRESSURE;
CONTROLLED STUDY;
ENZYME BLOOD LEVEL;
HEART LEFT VENTRICLE HYPERTROPHY;
HEART MUSCLE FIBROSIS;
HYPERTENSION;
MALE;
MORPHOLOGY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PLASMA RENIN ACTIVITY;
PRIORITY JOURNAL;
RAT;
SMOOTH MUSCLE CONTRACTILITY;
ADENOSINE TRIPHOSPHATE;
ANGIOTENSINS;
ANIMAL;
AORTA, THORACIC;
BLOOD PRESSURE;
CARDIOMEGALY;
CATECHOLAMINES;
CYCLIC GMP;
ENDOMYOCARDIAL FIBROSIS;
HYPERTENSION;
MALE;
MYOCARDIUM;
PEPTIDYL-DIPEPTIDASE A;
PHOSPHOCREATINE;
RADIOIMMUNOASSAY;
RAMIPRIL;
RATS;
RATS, INBRED SHR;
RATS, SPRAGUE-DAWLEY;
|
EID: 0026479028
PISSN: 00071188
EISSN: 14765381
Source Type: Journal
DOI: 10.1111/j.1476-5381.1992.tb13393.x Document Type: Article |
Times cited : (132)
|
References (31)
|